Displaying drugs 1426 - 1450 of 2774 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Brexanolone | 318.4935 C21H34O2 |  | Brexanolone is a synthetic neuroactive steroid gamma-aminobutyric acid A (GABA(a)) receptor positive modulator indicated for the treatment of postpartum depression (PPD) in adult women [FDA Label][A176080, A176083, F4063, F4066, F4072]. | Anesthetics / Anticonvulsants / GABA Modulators / Neurotransmitter Agents |
| Lapyrium | 363.521 C21H35N2O3 |  | Used as a surfactant, antistatic agent, and biocide in cosmetic products . | Pyridines |
| Amorolfine | 317.517 C21H35NO |  | A morpholine derivative commonly applied as a lacquer for onychomycosis but is also used for superficial dermatomycosis. | Antifungal Agents |
| Cetylpyridinium | 304.541 C21H38N |  | A compound used to reduce plaque and gingivitis, as well as whiten teeth. | Anti-Infective Agents / Anti-Infective Agents, Local / Medicated Dressings With Antiinfectives / Quaternary Ammonium Compounds |
| Streptomycin | 581.5741 C21H39N7O12 |  | An aminoglycoside antibiotic indicated to treat multi-drug resistant mycobacterium tuberculosis and various non-tuberculosis infections. | Streptomycins |
| Netilmicin | 475.587 C21H41N5O7 |  | An aminoglycoside used to treat a wide variety of infections in the body. | Anti-Bacterial Agents |
| Dihydrostreptomycin | 583.596 C21H41N7O12 |  | Dihydrostreptomycin is an aminoglycoside antibiotic. In humans, the use of dihydrostreptomycin has been associated with ototoxicity. The FDA withdrew its approval for the use of all drug products containing dihydrostreptomycin... | Anti-Bacterial Agents |
| Hexetidine | 339.6021 C21H45N3 |  | An topical antiseptic agent used for disinfection and prevention of bacterial, fungal and yeast infections of the oral and vaginal mucosa. | Antiinfectives and Antiseptics for Local Oral Treatment |
| Miltefosine | 407.576 C21H46NO4P |  | An antileishmanial agent used to treat leishmaniasis, a group of disease caused by parasites of the Leishmania type. | Antineoplastic Agents |
| Linzagolix | 508.42 C22H15F3N2O7S |  | A selective gonadotropin-releasing hormone (GnRH) receptor antagonist used for the symptomatic treatment of uterine fibroids. | Anti-Gonadotropin-Releasing Hormones |
| Clotrimazole | 344.837 C22H17ClN2 |  | A topical broad-spectrum antifungal agent used for the treatment of a wide variety of dermatophyte infections and candidiasis. | Antiinfectives and Antiseptics for Local Oral Treatment / Imidazole and Triazole Derivatives / Imidazole Derivatives |
| Duvelisib | 416.87 C22H17ClN6O |  | An inhibitor of phosphatidylinositol 3-kinase delta and gamma used to treat relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| Isavuconazole | 437.47 C22H17F2N5OS |  | Indicated for patients 18 years of age and older for the treatment of invasive aspergillosis [FDA Label]. Indicated for patients 18 years of age and older for the treatment of... | Triazole and tetrazole derivatives / Triazole Derivatives |
| Idelalisib | 415.432 C22H18FN7O |  | An antineoplastic kinase inhibitor used to treat chronic lymphocytic leukemia (CLL), relapsed follicular B-cell non-Hodgkin lymphoma (FL), and relapsed small lymphocytic lymphoma (SLL). | Phosphatidylinositol-3-kinase (Pi3K) inhibitors |
| Bifonazole | 310.3917 C22H18N2 |  | An azole antifungal drug used to treat fungal skin infections, such as dermatomycosis. | Imidazole and Triazole Derivatives |
| Axitinib | 386.47 C22H18N4OS |  | An oral VEGFR and kinase inhibitor used for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy. | Protein Kinase Inhibitors / Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| Rilpivirine | 366.4185 C22H18N6 |  | A non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with other antiretrovirals to specifically treat human immunodeficiency virus type 1 (HIV-1). | Non-Nucleoside Reverse Transcriptase Inhibitors |
| Tivozanib | 454.863 C22H19ClN4O5 |  | A kinase inhibitor to treat adult patients with renal cell carcinoma (RCC) who have failed prior systemic therapies or experienced relapsed disease. | Protein Kinase Inhibitors / Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors |
| Atovaquone | 366.837 C22H19ClO3 |  | An antimicrobial indicated for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP) and for the prevention and treatment of Plasmodium falciparum malaria. | Biguanides |
| Tadalafil | 389.404 C22H19N3O4 |  | A phosphodiesterase 5 inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. | 5-alpha Reductase Inhibitors / Antihypertensives for Pulmonary Arterial Hypertension / Drugs Used in Erectile Dysfunction |
| Bisacodyl | 361.3906 C22H19NO4 |  | A stimulant laxative used for the temporary relief of occasional constipation and cleansing of the colon as a preparation for colonoscopy in adults. | Enemas |
| Lemborexant | 410.425 C22H20F2N4O2 |  | A dual orexin antagonist indicated for the treatment of sleep-onset and/or sleep maintenance insomnia. | Orexin Receptor Antagonists |
| Rimonabant | 463.787 C22H21Cl3N4O |  | For use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m2, or patients wih a BMI greater than 27 kg/m2 with associated... | Agents producing tachycardia |
| Pirtobrutinib | 479.436 C22H21F4N5O3 |  | A kinase inhibitor used to treat relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy. | Enzyme Inhibitors |
| Ceftaroline fosamil | 684.67 C22H21N8O8PS4 |  | An antibacterial agent used to treat various bacterial infections, such as acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. | beta Lactam Antibiotics |
Displaying drugs 1426 - 1450 of 2774 in total